GLOCALCURE
Live / Registered — Registered (as of 24 Sept 2024)
What this means for you
Registered since 24 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97788906
- Registration number
- 7517568
- Mark type
- Stylized text
- Filed
- 09 Feb 2023
- Published for opposition
- 03 Oct 2023
- Registered
- 24 Sept 2024
- Attorney of record
- Zoe Bernstein
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Cosmetics; Non-medicated skin creams; Sun cream; Sun screen
- Class 005 — Pharmaceuticals: Dietary Supplements; Topical gels for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical creams being medicated skin creams for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical serums being medicated skin serums for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical toners being medicated skin toners for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Topical medicated fluids for medical and therapeutic treatment of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated serums for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated Creams for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Medicated Gels for the treatments of hair loss, hyperpigmentation, acne, psoriasis, rosacea, vitiligo, atopic dermatitis, scars, keloids, burns, pruritus, urticaria, erythema, demodicosis, bacterial vaginitis, fungi's, viral infections, vaginal dryness, vaginal atrophy; Gels, creams and solutions for dermatological use; Medicated Sun screen
- Class 010 — Medical apparatus: Pessaries; Medical devices for closing wounds; Medical devices for nonsurgical cosmetic treatment; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions; Medical devices, namely, hand-held motorized, vibrating devices used near injection sites for reducing pain during hypodermic needle injections; Light-based medical devices, namely, a light emitting diode (LED) device for increasing the human body's own production of collagen; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions with integrated recorded operating system software, sold as a unit; Medical devices for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical devices for use in treating or diagnosing dermatological, cosmetological and gynecological conditions with integrated recorded software for reporting dermatological, cosmetological and gynecological conditions, sold as a unit; Topical preparations, namely, sprays and gels, for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for subcutaneous preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for intra epidermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for intradermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo; medical apparatus, namely, injection devices for hypodermal preparations for dermatological procedures for treatment of aging, hyperpigmentation, hair loss, scars, keloids, cellulitis, acne, rosacea, vitiligo
- Class 035 — Advertising and business services: Online retail store services featuring dietary supplements, skin care preparations, cosmetics, medical devices, topical gels, topical serums, topical creams, medicated serums, medicated creams, medicated gels, pessaries, sun screens, topical toners
Owner
- Glocal Lab LLC, Irvine, CA, US
- Glocal Lab LLC, Irvine, CA, US
- Glocal Lab LLC, Irvine, CA, US
Prosecution history
- 24 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 26 May 2024 — USE AMENDMENT FILED
- 04 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Oct 2023 — PUBLISHED FOR OPPOSITION
- 13 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE